Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors - ScienceDirect
WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition | NEJM
Clinical implications of PTEN loss in prostate cancer | Nature Reviews Urology
Cleveland Clinic Designated PTEN Clinical Center of Excellence – Consult QD
PTEN Hamartoma Tumor Syndrome Foundation - PTEN Foundation
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) - European Journal of Cancer
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
Participation of HSP27, PTEN, p53 and P-gp in drug resistance. HSF1 can... | Download Scientific Diagram
Cancer risk and PTEN gene mutations
Phase II and phase III clinical trials with translational analyses... | Download Scientific Diagram
PTEN Hamartoma Tumor Syndrome Foundation - PTEN Foundation
References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
PTEN hamartoma tumor syndromes | European Journal of Human Genetics
How are new medicines developed? | PTEN Research
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia
PTEN Mutations Trigger Resistance to Immunotherapy: Trends in Molecular Medicine
Cancers | Free Full-Text | PTEN Tumor-Suppressor: The Dam of Stemness in Cancer | HTML
Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity | NEJM
Pharmacological PTEN inhibition: potential clinical applications and effects in tissue regeneration | Regenerative Medicine
JCI - PTEN-opathies: from biological insights to evidence-based precision medicine
